Filament Health Corp. (TSE:FH) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Filament Health Corp. and its joint venture, Magdalena Biosciences, have successfully imported six kilograms of coca leaf from Peru to Canada for developing natural prescription medicines targeting mental health conditions, such as ADHD. This marks their second authorized import, highlighting their commitment to exploring the therapeutic potential of coca leaf. The collaboration with the Peruvian government underscores the significant regulatory achievement for Filament Health in the psychedelic drug development space.
For further insights into TSE:FH stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- General Motors (NYSE:GM) Takes on the Taxpayer in Building Renovations
- Honda (NYSE:HMC) Looks to Ramp Up Hybrid Sales
- Air Canada (TSE:AC) Offers Guidance, Projects “Strong Revenue Growth” Eventually
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
